Victoria and Albert Museum, London
British Journal of Phytotherapy
This journal was (is?) published by the School of Phyotherapy in Sussex, UK starting in 1990. I have been unable to locate a website for the journal or any online source for its material, which is too bad as it is quite useful. I am at least publishing tables of contents for the earliest volumes. Please if anyone has any further information about this journal, use the contact page to let me know.
ISSN 0959-6879
ISSN 0959-6879
Vol 1(1), 1990 (spring)
Anonymous. What is herbal medicine? 6–9.
Stelling K. An approach to arteriosclerosis: Phyto-chelation. 10–15.
Evans WC. Deterioration of crude drugs on storage. 16–19.
Hyde FF. Herbal remedies influencing the heart and circulation: Part 1 (heart disease). 20–23.
Bove M. The echinacea species: A research review. 24–27.
Shellard EJ. The contribution of herbal remedies to modern medicine: A European perspective. 28–32.
Carle R. Anti-inflammatory and spasmolytic botanical drugs. 33–39.
Stelling K. An approach to arteriosclerosis: Phyto-chelation. 10–15.
Evans WC. Deterioration of crude drugs on storage. 16–19.
Hyde FF. Herbal remedies influencing the heart and circulation: Part 1 (heart disease). 20–23.
Bove M. The echinacea species: A research review. 24–27.
Shellard EJ. The contribution of herbal remedies to modern medicine: A European perspective. 28–32.
Carle R. Anti-inflammatory and spasmolytic botanical drugs. 33–39.
Vol 1(2), 1990 (summer)
Bone K. Liquorice--the universal herb. 7–13.
Hyde FF. Herbal remedies influencing the heart and circulation: Part 1 (hypertension). 14–21.
Evans DM. Hallucinogenic plants. 22–28.
Hunter A. Herbal medicine and natural therapies in Australia: What do we want for the future? 29–31.
Caldock K. Research herbal medicine: The need for innovation. 32–33.
T.S. (patient, name not fully disclosed). Case history. 34–35. (Echinacea purpurea for genital herpes)
Stelling K. Are standard doses unjustified? 36–37.
Hyde FF. Herbal remedies influencing the heart and circulation: Part 1 (hypertension). 14–21.
Evans DM. Hallucinogenic plants. 22–28.
Hunter A. Herbal medicine and natural therapies in Australia: What do we want for the future? 29–31.
Caldock K. Research herbal medicine: The need for innovation. 32–33.
T.S. (patient, name not fully disclosed). Case history. 34–35. (Echinacea purpurea for genital herpes)
Stelling K. Are standard doses unjustified? 36–37.
Vol 1(3/4), 1990 (autumn/winter)
Greinwald R, Stobernack HP. Ammi visnaga (khella). 7–10.
Van Rietschoten K. Plants with anti–inflammatory action. 11–18.
Nicholls C. Psoriasis. 19–25.
Evans WC. Medicinal and poisonous plants of the Solanaceae. 26–31.
Bone K. Coltsfoot––is it safe? 32–35.
Meier B, Liebi M. Medicinal plants containing salicin: Effectiveness and safety. 36–42.
Stainton RE. Verbena officinalis in perspective. 43–6.
National Centre for the People's Traditional Medicine. The rescue of the people's traditional medicine in Nicaragua. 47–53.
Evans DM. The validity of the hallucinogenic plant experience and its relationship to the drug problem facing the West. 54–7.
Mitchell H. The European Scientific Cooperative for Phytotherapy (ESCOP). 58–59.
Potterton D. Can we trust the researchers? 60–62.
Van Rietschoten K. Plants with anti–inflammatory action. 11–18.
Nicholls C. Psoriasis. 19–25.
Evans WC. Medicinal and poisonous plants of the Solanaceae. 26–31.
Bone K. Coltsfoot––is it safe? 32–35.
Meier B, Liebi M. Medicinal plants containing salicin: Effectiveness and safety. 36–42.
Stainton RE. Verbena officinalis in perspective. 43–6.
National Centre for the People's Traditional Medicine. The rescue of the people's traditional medicine in Nicaragua. 47–53.
Evans DM. The validity of the hallucinogenic plant experience and its relationship to the drug problem facing the West. 54–7.
Mitchell H. The European Scientific Cooperative for Phytotherapy (ESCOP). 58–59.
Potterton D. Can we trust the researchers? 60–62.
Vol 2(1), 1991 (spring)
Sonnenborn U, Proppert Y. Ginseng (Panax ginseng CA Meyer). 3–14.
Zeylstra H. The phytotherapeutic approach to rheumatoid arthritis. 15–20.
Schilcher H, Schulz V. Garlic recognized as an effective medicinal product? International symposium on Allium sativum. 21–24.
Blackwell R. An insight into aromatic oils: Lavender and tea tree. 25–30.
Brown PS. The vicissitudes of herbalism in late nineteenth– and early twentieth–century Britain: Part 1. 31–37.
Barker J. Notes towards a therapeutic model of phytotherapy in Britain. 38–45.
Zeylstra H. The phytotherapeutic approach to rheumatoid arthritis. 15–20.
Schilcher H, Schulz V. Garlic recognized as an effective medicinal product? International symposium on Allium sativum. 21–24.
Blackwell R. An insight into aromatic oils: Lavender and tea tree. 25–30.
Brown PS. The vicissitudes of herbalism in late nineteenth– and early twentieth–century Britain: Part 1. 31–37.
Barker J. Notes towards a therapeutic model of phytotherapy in Britain. 38–45.
Vol 2(2), 1991 (summer)
Bone K. Turmeric––the spice of life? 51–60.
Collisson RJ. Siberian ginseng (Eleutherococcus senticosus Maxim). 61–71.
Brooks DN. An onion in your ear. 72–75.
Mills S. Are herbs safe? 76–83.
Brown PS. The vicissitudes of herbalism in late nineteenth– and early twentieth–century Britain: Part 2. 84–92.
Collisson RJ. Siberian ginseng (Eleutherococcus senticosus Maxim). 61–71.
Brooks DN. An onion in your ear. 72–75.
Mills S. Are herbs safe? 76–83.
Brown PS. The vicissitudes of herbalism in late nineteenth– and early twentieth–century Britain: Part 2. 84–92.
Vol 2(3), 1991/2 (summer 1992)
Brinker F. Artemisia tridentata Nutt (big sagebrush). 97–114.
Bone K. Crataegus––more than the heart? 115–127.
Swoboda M, Meurer J. Treatment of atopic dermatitis with hamamelis ointment. 128–132. (note: title in table of contents differs from article slightly)
Stelling K. Psoriasis: An integrated approach for phytotherapy. 133–137.
Michie CA. Commiphora myrrha: A botanical remedy from antiquity. 138–142.
Bone K. Crataegus––more than the heart? 115–127.
Swoboda M, Meurer J. Treatment of atopic dermatitis with hamamelis ointment. 128–132. (note: title in table of contents differs from article slightly)
Stelling K. Psoriasis: An integrated approach for phytotherapy. 133–137.
Michie CA. Commiphora myrrha: A botanical remedy from antiquity. 138–142.
Vol 2(4), 1991/2 (winter 1992)
Carle R, Gomaa K. The medicinal use of matricariae flos. 147–153.
Pénoël D. Eucalyptus smithii essential oil and its use in aromatic medicine. 154–159.
Brinker F. The insecticidal and therapeutic activity of natural isobutylamides. 160–170.
Paskov D, Staneva D, Boyadjieva N. Achievements and prospects for the manufacture of plant pharmaceuticals in Bulgaria. 171–180.
Bone K. Report on the 45th and International Congress on Phytotherapy: Part 1. 181–184.
Dunford A. Phytotherapy and the National Health Service: A personal view. 185–187.
Pénoël D. Eucalyptus smithii essential oil and its use in aromatic medicine. 154–159.
Brinker F. The insecticidal and therapeutic activity of natural isobutylamides. 160–170.
Paskov D, Staneva D, Boyadjieva N. Achievements and prospects for the manufacture of plant pharmaceuticals in Bulgaria. 171–180.
Bone K. Report on the 45th and International Congress on Phytotherapy: Part 1. 181–184.
Dunford A. Phytotherapy and the National Health Service: A personal view. 185–187.
Vol 3(1), 1993/4 (summer 1993)
Reuter HD. Garlic (Allium sativum L) in the prevention and treatment of atherosclerosis. 3–9.
Brinker F. Larrea tridentata (DC) Coville (chaparral or creosote bush). 10–31.
Williams M. Eleutherococcus senticosus: The use of biological response modifiers in oncology. 32–37.
Schleich T, Schmidramsl H. The therapeutic use of lactobacillus. 38–46.
Bone K. Report on the 4th and International Congress on Phytotherapy: Part 2. 47–50.
Brinker F. Larrea tridentata (DC) Coville (chaparral or creosote bush). 10–31.
Williams M. Eleutherococcus senticosus: The use of biological response modifiers in oncology. 32–37.
Schleich T, Schmidramsl H. The therapeutic use of lactobacillus. 38–46.
Bone K. Report on the 4th and International Congress on Phytotherapy: Part 2. 47–50.
Vol 3(2), 1993/4 (winter 1993)
Bone K. Chronic fatigue syndrome and its herbal treatment. 55–60.
Stelling K. Bronchitis asthma. 61–66.
Cañigueral S, Vila R. Aloe. 67–75.
Steinhoff B. The legal situation of phytomedicines in Germany. 76–80.
Evans MJ. Herbal medicine: Expectations and outcome. 81–85.
Blackwell R. Report on the 1st Intercontinental Congress on Medicinal Plants and Phytotherapy. 86–91.
Stelling K. Bronchitis asthma. 61–66.
Cañigueral S, Vila R. Aloe. 67–75.
Steinhoff B. The legal situation of phytomedicines in Germany. 76–80.
Evans MJ. Herbal medicine: Expectations and outcome. 81–85.
Blackwell R. Report on the 1st Intercontinental Congress on Medicinal Plants and Phytotherapy. 86–91.
Vol 3(3), 1993/4 (summer 1994)
Brinker F. The rational treatment of coughs with botanical medicines. 101–112.
Oswald EH. Lapacho. 112–117.
Duraffourd C, Lapraz JC. The application of clinical phytotherapy in terrain medicine. 118–123.
Blake O, Booth R, Corrigan D. The tannin content of herbal teas. 124–127.
Bone K. Dose considerations in herbal medicine. 128–137.
Nicholls C. Report on the ESCOP symposium 'Research and Therapy with Phytomedicines.' 138–142.
Oswald EH. Lapacho. 112–117.
Duraffourd C, Lapraz JC. The application of clinical phytotherapy in terrain medicine. 118–123.
Blake O, Booth R, Corrigan D. The tannin content of herbal teas. 124–127.
Bone K. Dose considerations in herbal medicine. 128–137.
Nicholls C. Report on the ESCOP symposium 'Research and Therapy with Phytomedicines.' 138–142.
Vol 3(4), 1993/4 (winter 1994)
Bone K. Kava––a safe herbal treatment for anxiety. 147–153.
Brinker F. An overview of conventional, experimental, and botanical treatments of non–malignant prostate conditions. 154–176.
Lapraz P. Clinical phytotherapy in the treatment of common infectious illnesses. 177–184.
Barbour EK, Hamadeh SK, Nasr J, Hilan C, Talhouk R, Nader R. Comparison of immunomodulation and performance in poultry administered synthetic and herbal medicines. 185–189.
Steinhoff B. New developments regarding phytomedicines in Germany. 190–193.
Brinker F. An overview of conventional, experimental, and botanical treatments of non–malignant prostate conditions. 154–176.
Lapraz P. Clinical phytotherapy in the treatment of common infectious illnesses. 177–184.
Barbour EK, Hamadeh SK, Nasr J, Hilan C, Talhouk R, Nader R. Comparison of immunomodulation and performance in poultry administered synthetic and herbal medicines. 185–189.
Steinhoff B. New developments regarding phytomedicines in Germany. 190–193.
Vol 4(1), 1995/6 (summer 1995)
Reuter HD. Ginkgo biloba––botany, constituents, pharmacology and clinical trials. 3–20.
Dorn M. Improvement in raised lipid levels with artichoke juice (Cynara scolymus L). 21–26.
Bone K. Treating autoimmune disease––a phytotherapeutic perspective: Part 1. 27–33.
Wilkinson JA. The internet as a research and information tool for herbal medicine. 34–45.
Bone K. Update. 46–49. (Ginkgo and PMS, Ginkgo and multiple sclerosis, Juniperus not kidney irritant in rats, Mentha arvensis topical anodyne, clove oil wasp stings, insecticidal essential oils)
Dorn M. Improvement in raised lipid levels with artichoke juice (Cynara scolymus L). 21–26.
Bone K. Treating autoimmune disease––a phytotherapeutic perspective: Part 1. 27–33.
Wilkinson JA. The internet as a research and information tool for herbal medicine. 34–45.
Bone K. Update. 46–49. (Ginkgo and PMS, Ginkgo and multiple sclerosis, Juniperus not kidney irritant in rats, Mentha arvensis topical anodyne, clove oil wasp stings, insecticidal essential oils)
Vol 4(2), 1995/6 (winter 1995)
Harvey R. Lycopus europaeus L and Lycopus virginicus L: A review of scientific research. 55–65.
Duraffourd C. Illustration of the unity of the terrain. 66–71. (regarding endocrine herbs)
Bone K. Treating autoimmune disease––a phytotherapeutic perspective: Part 2. 72–88.
Zeylstra H. Posology in herbal medicine. 89–93.
Bone K. Update. 94–99. (Plantago lanceolata antitussive, Vitex antiprolactin in men, Vitex and PMS, Arnica topically for varicose veins, Cimicifuga and Hypericum for psychological menopausal symptoms, Valeriana and insomnia, Piper methysticum long–term for anxiety, carminative tablets for digestion, Humulus lupulus baths for insomnia, Allium sativum and fish oil)
Duraffourd C. Illustration of the unity of the terrain. 66–71. (regarding endocrine herbs)
Bone K. Treating autoimmune disease––a phytotherapeutic perspective: Part 2. 72–88.
Zeylstra H. Posology in herbal medicine. 89–93.
Bone K. Update. 94–99. (Plantago lanceolata antitussive, Vitex antiprolactin in men, Vitex and PMS, Arnica topically for varicose veins, Cimicifuga and Hypericum for psychological menopausal symptoms, Valeriana and insomnia, Piper methysticum long–term for anxiety, carminative tablets for digestion, Humulus lupulus baths for insomnia, Allium sativum and fish oil)
Vol 4(3), 1997 (summer)
Prabhakar YS, Suresh Kumar D. Crataeva nurvala: An Ayurvedic remedy for urological disorders. 103–109.
Bone K. Ginger. 110–120.
Cargill P. Successful therapy using garlic against a pathogenic yeast. 121–122.
Brinker F. A comparative review of Eclectic female regulators. 123–145.
Ernst E. Report on the 3rd Annual Symposium on Complementary Health Care. 146–147.
Bone K. Ginger. 110–120.
Cargill P. Successful therapy using garlic against a pathogenic yeast. 121–122.
Brinker F. A comparative review of Eclectic female regulators. 123–145.
Ernst E. Report on the 3rd Annual Symposium on Complementary Health Care. 146–147.
Vol 4(4), 1997 (winter)
Hilan C, Khazzakha K, Sfeir R. Antimicrobial effect of essential oil of Salvia libanotica (sage). 155–162.
Tripathi B, Sharma M, Upadhyay BN, Shukla RC, Suresh Kumar D. Antioxidant properties of Rubia cordifolia. 163–167.
Schar D. Grifola frondosa: A 'new' immunostimulant? 168–175.
Atherton P. Aloe vera revisited. 176–183.
Zeylstra H. Just yarrow? 184–189.
Bone K. Phytotherapy and irritable bowel syndrome. 190–198.
Barnes J. Report on the 4th Annual Symposium on Complementary Health Care. 199–200.
Tripathi B, Sharma M, Upadhyay BN, Shukla RC, Suresh Kumar D. Antioxidant properties of Rubia cordifolia. 163–167.
Schar D. Grifola frondosa: A 'new' immunostimulant? 168–175.
Atherton P. Aloe vera revisited. 176–183.
Zeylstra H. Just yarrow? 184–189.
Bone K. Phytotherapy and irritable bowel syndrome. 190–198.
Barnes J. Report on the 4th Annual Symposium on Complementary Health Care. 199–200.
Vol 5(1), 1998
Bone K. Echinacea: What makes it work? 3–7.
Zeylstra H. Filipendula ulmaria. 8–12.
Schar D. Grifola frondosa and the human immunodeficiency virus. 13–22.
Zeylstra H. Hamamelis virginiana. 23–28.
Syrimis A. Uncaria tomentosa: A review. 29–31.
FitzSimmons S. An introduction to essential fatty acids. 32–39.
Nicholls C. Aromatic medicine in the treatment of infections. 40–47.
Turner D. The phytochemistry of immunity boosting polysaccharides. 48–56.
Field G. Allopathic drugs used to treat the immune system. 57–61.
Zeylstra H. Filipendula ulmaria. 8–12.
Schar D. Grifola frondosa and the human immunodeficiency virus. 13–22.
Zeylstra H. Hamamelis virginiana. 23–28.
Syrimis A. Uncaria tomentosa: A review. 29–31.
FitzSimmons S. An introduction to essential fatty acids. 32–39.
Nicholls C. Aromatic medicine in the treatment of infections. 40–47.
Turner D. The phytochemistry of immunity boosting polysaccharides. 48–56.
Field G. Allopathic drugs used to treat the immune system. 57–61.